Bacteriophage (phage): viruses that infect bacteria

Structure and genomes

Typical tailed phages have a protein capsid that often takes a near-icosahedral form — a roughly 20‑sided geometric head — which contains the genetic material. Many also possess a tail and tail fibers that recognize and bind host cells. The outer shell is built from viral proteins (protein subunits) and functions as a protective hull and delivery system. Phage genomes may be single- or double-stranded DNA or RNA and range from a few thousand to several hundred thousand base pairs. Some genomes are compact, encoding only a handful of genes, while others carry hundreds.

Life cycles and interaction with hosts

Phage infection typically begins with adsorption to specific receptors on a bacterial surface, followed by injection of the viral genome into the cell. Inside the host, the genome reprograms bacterial machinery to replicate viral components, assemble new virions and release them. Two broad outcomes are common: a lytic cycle, in which the host is rapidly commandeered and lysed to release progeny; and a lysogenic or temperate pathway, where the phage genome integrates into the bacterium or persists without immediate lysis, sometimes altering host traits.

Ecology and abundance

Phages are ubiquitous in the biosphere. In marine environments they can reach very high concentrations — studies report up to 9×10⁸ particles per milliliter in some microbial mats — and a large fraction of bacterial cells may be infected at any given time. Through infection, phages influence bacterial population dynamics, nutrient cycling and horizontal gene transfer; they are also major drivers of microbial evolution, selecting for bacterial defense systems such as restriction enzymes and CRISPR-based immunity.

History and discovery

Bacteriophages were identified in the early 20th century and studied intensively thereafter. Early proponents proposed using them to treat bacterial diseases, a practice that saw regional adoption in the former Soviet Union and parts of Central Europe. The physical nature of phages was clarified with electron microscopy in the late 1930s. Interest in phage applications has resurged recently because of rising antibiotic resistant infections and the need for alternative antimicrobials.

Applications and significance

Phages have multiple practical uses. In medicine, experimental phage therapy treats bacterial infections, especially when antibiotics fail. In biotechnology they are used in techniques such as phage display to study protein interactions and to select peptides with desired properties. Phages are also applied in food safety and agriculture as targeted biocontrol agents to reduce pathogenic bacteria on food or in livestock.

Interactions with biofilms and clinical considerations

Phage effects on bacterial communities are complex. Some phages can help disrupt slimy bacterial aggregates called biofilms, improving clearance of infections that underlie conditions like pneumonia or complications in cystic fibrosis. Conversely, certain phage-host dynamics can stabilize or modify biofilms in ways that protect bacteria from antibiotics and prolong infection. Clinical use therefore requires careful selection of phages, understanding of host range and monitoring for bacterial resistance.

Notable distinctions and ongoing research

• Most known bacterial viruses fall into a group with tails (order Caudovirales), but filamentous and other morphologies exist.
• Phages contribute to horizontal gene transfer by transduction, sometimes moving toxin or resistance genes between bacteria; this is both an ecological force and a biosafety concern.
• Bacterial defense mechanisms such as CRISPR-Cas systems reflect an evolutionary arms race between phages and their hosts.

Phage biology remains an active research area, spanning ecology, evolution, medicine and biotechnology. For further reading and specific resources see related entries and specialized reviews: eukaryotic viruses, plant viruses, animal viruses, and introductions to phage therapy practiced historically in France and developed regions. Additional context about natural habitats and sampling can be found in work on microbial mats and environmental virology.

For concise reference points on common phage-related topics consult resources linked here: virus, bacteria, bacterial ecology, and applied areas including protein structure and viral capsids. Historical and clinical perspectives touch on discoveries, early therapeutic use and modern challenges in countering antimicrobial resistance.